StockNews.com Initiates Coverage on BIOLASE (NASDAQ:BIOL)

Stock analysts at StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report issued on Sunday. The brokerage set a “sell” rating on the medical technology company’s stock.

BIOLASE Stock Performance

BIOLASE stock opened at $0.01 on Friday. The stock has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.02. The company has a market capitalization of $330,729.30, a P/E ratio of 0.00 and a beta of 0.67. BIOLASE has a fifty-two week low of $0.02 and a fifty-two week high of $1.94.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.